| CYP21A2 |
P08686
|
cytochrome P450 family 21 subfamily A member 2
|
|
2.6E-04 |
0.525 |
0.769 |
| HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
| UBE2L3 |
P68036
|
ubiquitin conjugating enzyme E2 L3
|
Enzyme
|
0.84 |
0.644 |
0.615 |
| HLA-DPB1 |
P04440
|
major histocompatibility complex, class II, DP beta 1
|
Immune response
|
5.3E-10 |
0.453 |
0.923 |
| TRIM31 |
Q9BZY9
|
tripartite motif containing 31
|
|
4.3E-06 |
0.626 |
0.577 |
| EHMT2 |
Q96KQ7
|
euchromatic histone lysine methyltransferase 2
|
Epigenetic regulator
|
1.0E-04 |
0.590 |
0.808 |
| HLA-DPA1 |
P20036
|
major histocompatibility complex, class II, DP alpha 1
|
Immune response
|
2.5E-06 |
0.552 |
0.846 |
| DLC1 |
Q96QB1
|
DLC1 Rho GTPase activating protein
|
|
1.00 |
0.529 |
0.731 |
| EHMT2-AS1 |
|
EHMT2 and SLC44A4 antisense RNA 1
|
|
|
0.780 |
0.462 |
| CDK14 |
O94921
|
cyclin dependent kinase 14
|
Kinase
|
2.5E-08 |
0.659 |
0.423 |
| TCF19 |
Q9Y242
|
transcription factor 19
|
|
9.4E-04 |
0.674 |
0.692 |
| HLA-DPA2 |
|
major histocompatibility complex, class II, DP alpha 2 (pseudogene)
|
|
|
0.780 |
0.538 |
| HLA-DQB2 |
P05538
|
major histocompatibility complex, class II, DQ beta 2
|
Immune response
|
4.3E-02 |
0.573 |
0.731 |
| MICD |
|
MHC class I polypeptide-related sequence D (pseudogene)
|
|
|
0.861 |
0.231 |